A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

Lupin share price fell after the United States Food and Drug Administration (USFDA) issued 3 observations for its Pithampur ...

Lupin share price slipped in trade after the company announced that United States Food and Drug Administration (USFDA) has ...

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with ...

Mumbai: Global pharma major Lupin Limited has announced that it has signed a distribution agreement with Scope Ophthalmics ...

To learn more, please visit aytubio.com. About Lupin Limited Lupin Limited is a global pharmaceutical leader headquartered in Mumbai, India, with products distributed in over 100 markets.

Usage of generic medicines has been increased as they became boon to the poor and middle-class people because they are ...

This acquisition will enable Lupin gain access to MNI’s wide portfolio of nine brands, that are marketed as branded products in the South African retail sector, the company stated.

Lupin to distribute Scope Ophthalmics’ Optase range of products in Mexico: Our Bureau, Mumbai Monday, September 30, 2024, 17:50 Hrs [IST] Global pharma major Lupin Limited (Lupi ...

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...

and Lupin Pharma Canada Ltd ("Lupin"), a subsidiary of global pharma major Lupin Limited, today announced the signing of an exclusive collaboration, distribution and supply agreement for Aytu's ...

Once approved by Health Canada, Adzenys and Cotempla will be the only orally disintegrating, extended-release tablets for the treatment of ADHD commercialized in Canada DENVER, CO / ACCESSWIRE / ...